The WIN Symposium is dedicated to precision and molecular oncology.
The WIN Symposium covers topics such as:
- Best practices in using biomarker-based algorithms for cancer treatment selection, optimization, and monitoring
- Established and emerging biomarkers with diagnostic, prognostic, or predictive value in contemporary cancer management
- How principles of precision oncology can be applied to radiation therapy
- Design specifics and clinical implications of research studies and clinical trials assessing new biomarkers for immunotherapy and targeted therapy
- Issues of access , diversity and equity in precision oncology practice and clinical trials
The WIN Symposium brings together:
- Researchers
- Expert clinicians
- Industry professionals
The WIN Symposium might be held in 2025.
